logo-annsaudimed

Frequency:


Impact factor: 3.623


Google Scholar h5 Index: 43


Contact:
info@liebertpub.com

Disciplines/Subjects/Topics:
Vector developments, Delivery systems, Cell therapy, Nucleic acid, RNAi, Clinical trials, Gene and cell therapy, Clinical trials, Issues related to the commercial development of gene and cell therapy products

Publisher: Mary Ann Liebert, Inc.

Started in: 1990

Journal Language(s): N/A

Has Publiation Charge(s)?:

Publication Charge(s): No Information Available

Keywords: , , , ,

Publication Medium:

ISSN(Online): 1557-7422

ISSN(Print): 1043-0342

Used Digital Object Identifier (DOI):

Indexed in PubMed:

Availability in HINARI:

Assigned BIOJ: 15-0000071

Country of Publication:

Added to Bioj: 20/05/2015

Homepage: Click here to Enter

Rate this Journal:

1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

Description:


Human Gene Therapy is the premier, multidisciplinary journal covering all aspects of gene therapy. The Journal publishes in-depth coverage of DNA, RNA, and cell therapies by delivering the latest breakthroughs in research and technologies. Human Gene Therapy provides a central forum for scientific and clinical information, including ethical, legal, regulatory, social, and commercial issues, which enables the advancement and progress of therapeutic procedures leading to improved patient outcomes, and ultimately, to curing diseases. The Journal is divided into three parts. Human Gene Therapy, the flagship, is published 12 times per year. HGT Methods, a bimonthly journal, focuses on the applications of gene therapy to product testing and development. HGT Clinical Development, a quarterly journal, serves as a venue for publishing data relevant to the regulatory review and commercial development of cell and gene therapy products.


Leave a Reply